Patterson Companies Inc. (PDCO) has been downgraded today from “buy” to “neural” by the research analysts at UBS. UBS also increased their price target for PDCO from $36 to $37 dollars. PDCO closed trading down at $35.79.
Patterson Companies is slated to release their next earnings report on May 26 and is estimated to post EPS of 51 cents. Their last earnings report was released on February 24, 2011 and announced EPS of 47 cents with revenue totaling 833.10 million which was up 0.6 % year to year. Patterson Companies is currently trading above its 50 & 200-day moving averages and 2011 is currently an up year for the company.
Patterson’s operating units include Patterson Dental, Webster Veterinary and Patterson Medical. The company has market capitalization of $4,309,000,000 and 122,757,000 shares outstanding. PDCO has a 52-week high of $36.93 with the low being $24.88.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.